Sale!

AP5Z1 Gene SPG48 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AP5Z1 gene SPG48 genetic test is a specialized diagnostic tool designed to identify mutations in the AP5Z1 gene, which are linked to a rare condition known as Spastic Paraplegia 48 (SPG48). This condition is part of a group of disorders known as hereditary spastic paraplegias, which are characterized by progressive stiffness and weakness of the legs. The test is crucial for individuals displaying symptoms of SPG48 or those with a family history of the disorder, as it can confirm the diagnosis and assist in the development of a tailored management plan.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient’s DNA sample, typically obtained through a blood draw, to detect any genetic abnormalities in the AP5Z1 gene. The process is comprehensive, employing advanced genetic sequencing technologies to ensure accurate and reliable results.

The cost of the AP5Z1 gene SPG48 genetic test at DNA Labs UAE is set at 4400 AED. While the price might seem significant, the value of the test lies in its ability to provide crucial insights into the patient’s condition, thereby enabling informed decisions about treatment and management options. It’s an investment in health that could significantly impact the quality of life for individuals affected by SPG48, offering them a clearer path towards managing their condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AP5Z1 Gene SPG48 Genetic Test

Test Name: AP5Z1 Gene SPG48 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for AP5Z1 Gene SPG48 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AP5Z1 Gene SPG48

Test Details

The AP5Z1 gene is associated with a specific form of hereditary spastic paraplegia (HSP) known as SPG48. HSP is a group of inherited neurological disorders characterized by progressive weakness and stiffness of the legs (paraplegia) due to degeneration of the corticospinal tract, which is responsible for controlling muscle movement.

The NGS genetic test for SPG48 aims to identify mutations or variations in the AP5Z1 gene that may be responsible for causing the condition. NGS stands for next-generation sequencing, which is a high-throughput technology used to analyze DNA sequences quickly and accurately.

This genetic test can be used to confirm a diagnosis of SPG48 in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in individuals with a family history of SPG48, as the condition is inherited in an autosomal recessive manner, meaning that both copies of the AP5Z1 gene must be affected for the disease to manifest.

By identifying the specific genetic cause of SPG48, NGS genetic testing can provide valuable information for genetic counseling, family planning, and potential future therapeutic interventions. It is important to consult with a healthcare professional or genetic counselor for further information and guidance regarding this genetic test.

Test Name AP5Z1 Gene SPG48 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AP5Z1 Gene SPG48 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AP5Z1 Gene SPG48
Test Details

The AP5Z1 gene is associated with a specific form of hereditary spastic paraplegia (HSP) known as SPG48. HSP is a group of inherited neurological disorders characterized by progressive weakness and stiffness of the legs (paraplegia) due to degeneration of the corticospinal tract, which is responsible for controlling muscle movement.

The NGS genetic test for SPG48 aims to identify mutations or variations in the AP5Z1 gene that may be responsible for causing the condition. NGS stands for next-generation sequencing, which is a high-throughput technology used to analyze DNA sequences quickly and accurately.

This genetic test can be used to confirm a diagnosis of SPG48 in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in individuals with a family history of SPG48, as the condition is inherited in an autosomal recessive manner, meaning that both copies of the AP5Z1 gene must be affected for the disease to manifest.

By identifying the specific genetic cause of SPG48, NGS genetic testing can provide valuable information for genetic counseling, family planning, and potential future therapeutic interventions. It is important to consult with a healthcare professional or genetic counselor for further information and guidance regarding this genetic test.